Publications | Epilepsy kinase CDKL5 is a DNA damage sensor which controls transcriptional activity at DNA breaks

Mutation of the CDKL5 kinase gene leads to the seizure-prone neurodevelopmental condition CDD (CDKL5 deficiency disorder) and is the most common genetic cause of childhood epilepsy. However, the phospho-targets and roles of CDKL5 are poorly understood, especially in the nucleus. We reveal CDKL5 as a sensor of DNA damage in actively transcribed regions of the nucleus, which phosphorylates transcriptional regulators such as Elongin A (ELOA) on a specific consensus motif. Recruitment of CDKL5 and ELOA to DNA damage sites, and subsequent ELOA phosphorylation, requires both active transcription and synthesis of poly–ADP ribose to which CDKL5 can bind. Critically, CDKL5 is essential for transcriptional control at DNA breaks. Therefore, CDKL5 is a DNA damage-sensing regulator of transcription, with implications for CDKL5-related human diseases.

Principal Investigator(s):

Author(s):
Khanam, T., Muñoz, I. M., Weiland, F., Morgan, M., Borsos, B., Pantazi, V., Slean, M., Novak, M., Toth, R., Appleton, P., Pankotai, T., Zhou, H. and Rouse, J.

Paper:
Online paper
Citation:
Khanam, T., Muñoz, I. M., Weiland, F., Morgan, M., Borsos, B., Pantazi, V., Slean, M., Novak, M., Toth, R., Appleton, P., Pankotai, T., Zhou, H. and Rouse, J.
bioRxiv
2020
Dec
doi:
10.1101/2020.12.10.419747v3